{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:31:49Z","timestamp":1707525109244},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,16]]},"DOI":"10.7759\/cureus.40533","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T20:22:06Z","timestamp":1686946926000},"source":"Crossref","is-referenced-by-count":0,"title":["Nivolumab-Induced PRES (Posterior Reversible Encephalopathy Syndrome)"],"prefix":"10.7759","author":[{"given":"Kanica","family":"Yashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaswinder","family":"Virk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taral","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-159741","article-title":"Posterior reversible encephalopathy syndrome: a rare side effect of nivolumab","author":"Abedin MSU","unstructured":"Abedin MSU. Posterior reversible encephalopathy syndrome: a rare side effect of nivolumab. Blood. 10.1182\/blood-2022-159741","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.2122","article-title":"Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non-small\u2010cell lung cancer","volume":"7","author":"Kim D","year":"2019","unstructured":"Kim D. Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non-small\u2010cell lung cancer. Clin Case Rep. 2019, 7:935-8. 10.1002\/ccr3.2122","journal-title":"Clin Case Rep"},{"key":"ref3","article-title":"Posterior reversible encephalopathy syndrome","author":"Zelaya JE","unstructured":"Zelaya JE, Al-Khoury L. Posterior reversible encephalopathy syndrome. StatPearls,"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000362","article-title":"Nivolumab-induced posterior reversible encephalopathy syndrome","volume":"7","author":"Hussein HM","year":"2017","unstructured":"Hussein HM, Dornfeld B, Schneider DJ. Nivolumab-induced posterior reversible encephalopathy syndrome. Neurol Clin Pract. 2017, 7:455-6. 10.1212\/CPJ.0000000000000362","journal-title":"Neurol Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.07.601","article-title":"Nivolumab-induced atypical presenting as status epilepticus","author":"Tuttle E","unstructured":"Tuttle E. Nivolumab-induced atypical presenting as status epilepticus. Chestnet. 10.1016\/j.chest.2021.07.601","journal-title":"Chestnet"},{"key":"ref6","article-title":"Nivolumab","author":"Adriana Rendon","unstructured":"Adriana Rendon. Nivolumab. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567801\/,"},{"key":"ref7","article-title":"A reversible posterior leucoencephalopathy syndrome including blindness caused by preeclampsia","volume":"8","author":"Vandenbossche G","year":"2016","unstructured":"Vandenbossche G, Maquet J, Vroonen P, Lambert G, Nisolle M, Kridelka F, Emonts E. A reversible posterior leucoencephalopathy syndrome including blindness caused by preeclampsia. Facts Views Vis Obgyn. 2016, 8:173-7.","journal-title":"Facts Views Vis Obgyn"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2012.00152","article-title":"Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness","volume":"32","author":"Hobson EV","year":"2012","unstructured":"Hobson EV, Craven I, Blank SC. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Perit Dial Int. 2012, 32:590-4. 10.3747\/pdi.2012.00152","journal-title":"Perit Dial Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050360","article-title":"Cyclosporine neurotoxicity: a review","volume":"246","author":"Gijtenbeek JM","year":"1999","unstructured":"Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol. 1999, 246:339-46. 10.1007\/s004150050360","journal-title":"J Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features","volume":"29","author":"Bartynski WS","year":"2008","unstructured":"Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. Am J Neuroradiol. 2008, 29:1036-42. 10.3174\/ajnr.A0928","journal-title":"Am J Neuroradiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer M","year":"2017","unstructured":"Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017, 264:1608-16. 10.1007\/s00415-016-8377-8","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/2347-9264.165442","article-title":"Corticosteroid - an uncertainty in management of sepsis","author":"Kanica Yashi","unstructured":"Kanica Yashi. Corticosteroid - an uncertainty in management of sepsis. https:\/\/parjournal.net\/article\/view\/1218, 10.4103\/2347-9264.165442"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29941","article-title":"Hepatitis B vaccine and multiple sclerosis: cause or coincidence","volume":"14","author":"Luhadia K","year":"2022","unstructured":"Luhadia K, Abugrin M, Kiani R, Ahmady A, Virk J, Yashi K. Hepatitis B vaccine and multiple sclerosis: cause or coincidence. Cureus. 2022, 14:e29941. 10.7759\/cureus.29941","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29950","article-title":"Blurry diagnosis of ocular syphilis","volume":"14","author":"Kiani R","year":"2022","unstructured":"Kiani R, Ahmady A, Luhadia K, Abugrin M, Virk J, Yashi K. Blurry diagnosis of ocular syphilis. Cureus. 2022, 14:e29950. 10.7759\/cureus.29950","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2022.01.155","article-title":"CRT-200.08 outcomes of acute coronary syndrome in patients with coronavirus 2019 infection: a systematic review and meta-analysis","volume":"15","author":"Abdelghany M","year":"2022","unstructured":"Abdelghany M, Virk J, Raj V, et al.. CRT-200.08 outcomes of acute coronary syndrome in patients with coronavirus 2019 infection: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2022, 15:S29-30. 10.1016\/j.jcin.2022.01.155","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/164206-nivolumab-induced-pres-posterior-reversible-encephalopathy-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:52Z","timestamp":1707508972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/164206-nivolumab-induced-pres-posterior-reversible-encephalopathy-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.40533","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}